Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Docetaxel Before Medical Castration With Degarelix in Patients With Newly Diagnosed Metastatic Prostatic Adenocarcinoma.

NCT03069937 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03069937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03069937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Docetaxel Before Medical Castration With Degarelix in Patients With Newly Diagnosed Metastatic Prostatic Adenocarcinoma.
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2017
Completion date
December 11, 2024
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostatic adenocarcinoma